
	Unrealized Gain (Loss) on Investments, Net		Unrealized Gain (Loss) on Derivative Instruments Qualifying as Cash Flow Hedges		Defined and Postretirement Benefit Plans		Cumulative Translation Adjustments		Total

	(in millions)
Balance as of October 26, 2025	$	11	$	(34)	$	(100)	$	13	$	(110)


Other comprehensive income (loss) before reclassifications	(10)		25		—		—		15
Amounts reclassified out of AOCI	(9)		(20)		—		—		(29)
Other comprehensive income (loss), net of tax	(19)		5		—		—		(14)
Balance as of April 26, 2026	$	(8)	$	(29)	$	(100)	$	13	$	(124)


	Unrealized Gain (Loss) on Investments, Net		Unrealized Gain (Loss) on Derivative Instruments Qualifying as Cash Flow Hedges		Defined and Postretirement Benefit Plans		Cumulative Translation Adjustments		Total

	(in millions)
Balance as of October 27, 2024	$	(7)	$	(87)	$	(87)	$	13	$	(168)


Other comprehensive income (loss) before reclassifications	5		13		—		—		18
Amounts reclassified out of AOCI	—		6		—		—		6
Other comprehensive income (loss), net of tax	5		19		—		—		24
Balance as of April 27, 2025	$	(2)	$	(68)	$	(87)	$	13	$	(144)

In March 2025, our Board of Directors approved a common stock repurchase program authorizing $10.0 billion in repurchases, which supplemented the previous $10.0 billion authorization approved in March 2023. As of April 26, 2026, approximately $13.2 billion remained available for future stock repurchases under the repurchase program.


	Three Months Ended				Six Months Ended
	April 26, 2026		April 27, 2025		April 26, 2026		April 27, 2025

	(in millions, except per share amount)
Shares of common stock repurchased	1		11		2		19
Cost of stock repurchased (including excise tax)*	$	400	$	1,685	$	737	$	2,999
Average price paid per share (including excise tax)*	$	352.63	$	148.88	$	302.69	$	159.77
Cost of stock repurchased (excluding excise tax)	$	400	$	1,670	$	737	$	2,975
Average price paid per share (excluding excise tax)	$	352.63	$	147.59	$	302.69	$	158.47

(*) Stock repurchase amounts include the 1% surcharge on stock repurchases under the Inflation Reduction Act’s excise tax. This excise tax is recorded in equity and reduces the amount available under the repurchase program, as applicable.

We record common stock repurchased and held as treasury stock under the cost method using the first-in, first-out method. Upon reissuance of treasury stock, amounts in excess of the acquisition cost are credited to additional paid in capital. If we reissue treasury stock at an amount below our acquisition cost and additional paid in capital associated with prior treasury stock transactions is insufficient to cover the difference between the acquisition cost and the reissue price, this difference is recorded against retained earnings.

In March 2026 and December 2025, our Board of Directors declared quarterly cash dividends in the amount of $0.53 and $0.46 per share, respectively. The dividend declared in March 2026 is payable in June 2026. Dividends paid during the six months ended April 26, 2026 and April 27, 2025 totaled $730 million and $651 million, respectively. We currently anticipate that cash dividends will continue to be paid on a quarterly basis, although the declaration of any future cash dividend is at the discretion of the Board of Directors and will depend on our financial condition, results of operations, capital requirements, business conditions and other factors, as well as a determination by the Board of Directors that cash dividends are in the best interests of our stockholders.

We have a stockholder-approved equity plan, the Employee Stock Incentive Plan (ESIP), which permits grants to employees of share-based awards, including stock options, stock appreciation rights, restricted stock, restricted stock units, performance share units and performance units. In addition, the plan provides for the automatic grant of restricted stock units to non-employee directors and permits the grant of share-based awards to non-employee directors and consultants. Share-based awards made under the plan may be subject to accelerated vesting under certain circumstances, including in the event of a change in control. In addition, we have an Omnibus Employees’ Stock Purchase Plan (ESPP), which enables eligible employees to purchase our common stock.

During the three and six months ended April 26, 2026 and April 27, 2025, we recognized share-based compensation expense related to share-based awards and ESPP shares. The effect of share-based compensation on the results of operations was as follows:


	Three Months Ended				Six Months Ended
	April 26, 2026		April 27, 2025		April 26, 2026		April 27, 2025

	(In millions)
Cost of products sold	$	45	$	40	$	88	$	78
Research, development and engineering	70		64		143		131
Marketing and selling	20		22		41		42
General and administrative	34		33		104		103

Total share-based compensation	$	169	$	159	$	376	$	354

The cost associated with share-based awards is typically recognized over the awards’ service period for the entire award on a straight-line basis, adjusting for estimated forfeitures. However, in the case of share-based awards granted to certain members of senior management that allow for partial accelerated vesting in the event of a qualifying retirement based on age and years of service, the compensation expense is recognized once the individual meets the conditions for a qualifying retirement. We calculate the estimated forfeiture rate on an annual basis, based on historical forfeiture activities. The cost associated with share-based awards that include performance and/or market goals is recognized for each tranche over the service period. The cost of the portion of share-based awards subject to performance goals is recognized based on an assessment of the likelihood that the applicable performance goals will be achieved, and the cost of the portion of share-based awards subject to market goals is recognized based on the assumption of 100% achievement of the goal.

As of April 26, 2026, we had $1.3 billion in total unrecognized compensation expense, net of estimated forfeitures, related to grants of share-based awards under the ESIP and shares issued under the ESPP, which will be recognized over a weighted average period of 2.8 years. As of April 26, 2026, there were 15 million shares available for grant of share-based awards under the ESIP, and an additional 7 million shares available for issuance under the ESPP.

A summary of the changes in restricted stock units, restricted stock, performance share units and performance units outstanding under our equity compensation plans during the six months ended April 26, 2026 is presented below:


	Shares	Weighted Average Grant Date Fair Value

	(In millions, except per share amounts)
Outstanding as of October 26, 2025	9	$	148.43
Granted	3	$	268.45
Vested	(3)	$	144.90
Canceled	(1)	$	154.52
Outstanding as of April 26, 2026	8	$	191.03

A summary of the weighted-average grant date fair value per share of the granted restricted stock units, restricted stock, performance share units and performance units and total fair value vested awards for indicated periods is presented below:


	Six Months Ended
	April 26, 2026		April 27, 2025
	(In millions, except per share amounts)
Weighted average grant date fair value per share of awards granted	$	268.45	$	166.52
Total fair value of vested awards	$	444	$	441

During the first quarter of fiscal 2026, certain members of senior management were granted both awards subject solely to time-based vesting requirements and awards that are subject to the achievement of certain levels of specific performance and market goals, in addition to time-based vesting requirements (Performance-Based Awards). These Performance-Based Awards are subject to the achievement of targeted levels of non-GAAP economic profit and targeted levels of total shareholder return (TSR) relative to the TSR of the companies in the Standard & Poor’s 500 Index. Each of these two metrics will be weighted 50% and will be measured over a three-year period.

The number of Performance-Based Awards that may vest in full after three years ranges from 0% to 200% of the target amount. The awards become eligible to vest only if the goals are achieved and will vest only if the grantee remains employed by us through each applicable vesting date, subject to a qualifying retirement based on age and years of service. The awards provide for a partial vesting based on actual performance at the conclusion of the three-year performance period in the event of a qualifying retirement.

Under the ESPP, substantially all employees may purchase our common stock through payroll deductions at a price equal to 85 percent of the lower of the fair market value of our common stock at the beginning or end of each 6-month purchase period, subject to certain limits. Our purchasing cycles begin in March and September of each fiscal year. We issued a total of 1 million shares in each of the three and six months ended April 26, 2026 and April 27, 2025. Compensation expense is calculated using the fair value of the employees’ purchase rights under the Black-Scholes model. Underlying assumptions used in the model are outlined in the following table:



	Three and Six Months Ended
	April 26, 2026	April 27, 2025

Dividend yield	0.57%	1.21%
Expected volatility	49.7%	42.3%
Risk-free interest rate	3.64%	4.27%
Expected life (in years)	0.5	0.5
Weighted average estimated fair value	$109.16	$41.47